Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.

Date publication

janvier 2023

Journal

Radiation oncology (London, England)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine , Pr NOEL Georges , Dr CEBULA Hélène , Dr LE FEVRE Clara

Tous les auteurs :
Kuntz L, Le Fèvre C, Jarnet D, Keller A, Meyer P, Thiery A, Cebula H, Noel G, Antoni D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36717863

Résumé

Brain metastases (BMs) are the leading cause of intracranial malignant neoplasms in adults. WHO, Karnofsky performance status (KPS), age, number of BMs, extracerebral progression (ECP), recursive partitioning analysis (RPA), diagnosis-specific graded prognostic assessment (Ds-GPA) are validated prognostic tools to help clinicians decide on treatment. No consensus exists for repeat stereotactic radiotherapy (SRT) for BMs. The aim of this study was to review the changes in patient characteristics treated with repeated SRTs.

Mots clés

Brain metastases, Oligorecurrence, Radiotherapy, Reirradiation, Repeated radiosurgery, Salvage radiation, Stereotactic radiosurgery

Référence

Radiat Oncol. 2023 01 30;18(1):21